test

Jack Trottier

@Birchview Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$115.222MTotal holdings61
Assets growth rate6.73%Assets growth rate (2-Q avg)-2.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Birchview Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 61 positions.

Assets under management

The assets under management (AUM) of Birchview Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 115.222M in assets, with a quarterly growth rate of 6.73% and a 2-quarter average growth rate of -2.56%. The portfolio is managed by Jack Trottier, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BMYBristol-myers Squibb Co
Recent Activity
Decreased -0.29%
30.82%
$35.503M
686,182 shares@ $51.74 avg price
BDSXBiodesix Inc
Recent Activity
8.56%
$9.855M
5.541M shares@ $1.78 avg price
ACADAcadia Pharmaceuticals Inc
Recent Activity
Increased 59.91%
5.35%
$6.158M
400,400 shares@ $15.38 avg price
ELUTElutia Inc
Recent Activity
Decreased -14.85%
4.37%
$5.034M
1.321M shares@ $3.81 avg price
UTHRUnited Therapeutics Corp
Recent Activity
3.12%
$3.584M
10,000 shares@ $358.35 avg price
PRTAProthena Corp Plc
Recent Activity
Increased 2.95%
3.05%
$3.506M
209,574 shares@ $16.73 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Decreased -28.4%
3.03%
$3.484M
30,240 shares@ $115.23 avg price
CORTCorcept Therapeutics Inc
Recent Activity
2.98%
$3.425M
74,000 shares@ $46.28 avg price
HROWHarrow Health Inc
Recent Activity
Decreased -51.39%
2.85%
$3.278M
72,910 shares@ $44.97 avg price
7483⤦Quidelortho Corp
Recent Activity
2.68%
$3.083M
67,619 shares@ $45.6 avg price